Announce of the first publication using our Patient-Derived Tumor Xenograft (PDTX) models in Cells journal
27/07/2023 Publications Announce of the first publication using our Patient-Derived Tumor Xenograft (PDTX) models in Cells journal We are pleased to announce that the first paper related to study of…
Publication in Frontiers in Pharmacology on Optimizing the Enzymatic Release of MMAE from isoDGR-based SMDC by Incorporation of a GPLG-PABC Enzymatically Cleavable Linker
01/09/2023 Publications Publication in Frontiers in Pharmacology on Optimizing the Enzymatic Release of MMAE from isoDGR-based SMDC by Incorporation of a GPLG-PABC Enzymatically Cleavable Linker As a member of Magicbullet::Reloaded…
Published a study about Activation-Free Sulfonyl Fluoride Probes for Fragment Screening
01/09/2023 Publications Published a study about Activation-Free Sulfonyl Fluoride Probes for Fragment Screening In Molecules journal was published the research about synthesis and characterization of a small sulfonyl fluoride library…
Publication in European Journal of Medicinal Chemistry on covalent fragment mapping of KRasG12C which reveals novel chemotypes with in vivo potency
01/09/2023 Publications Publication in European Journal of Medicinal Chemistry on covalent fragment mapping of KRasG12C which reveals novel chemotypes with in vivo potency As a member of KRAS Consortium, KINETO…
Published a new study on Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy
10/02/2023 Publications Published a new study on Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy KINETO Lab took a part in development of Bombesin-Based Peptide–Drug Conjugates, acting as drug…
Published a new study on Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo
07/11/2022 Publications Published a new study on Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo By applying the computational methods…
Announced publication in Vaccines (Basel) on A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine
07/09/2022 Publications Announced publication in Vaccines (Basel) on A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine We are pleased to announce that our newest paper in the journal Vaccines (Basel)…